Rick Bhatt
MD
Associate Professor of GI Oncology and Pharmacology
👥Biography 个人简介
Rick Bhatt studies the pharmacogenomics of irinotecan metabolism, focusing on how UGT1A1 variants affect SN-38 glucuronidation and the risk of severe neutropenia and diarrhea. His research has refined dosing recommendations for irinotecan based on UGT1A1 genotype and has evaluated strategies to safely administer higher doses to normal metabolizers. He has examined the clinical utility of UGT1A1 screening in routine colorectal cancer practice and developed educational programs for oncologists on pharmacogenomics-guided prescribing. His work has improved the safety of irinotecan-based chemotherapy regimens.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Rick Bhatt 的研究动态
Follow Rick Bhatt's research updates
留下邮箱，当我们发布与 Rick Bhatt（University of North Carolina at Chapel Hill）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment